Affibody’s ABY-271 breast cancer trial cleared to progress to next phase
The TRC found that the therapy demonstrated targeted tumour activity and a low uptake in kidneys and other vital organs.
Clinical Trials
First patient treated in trial of Beacon Therapeutics’ XLRP treatment
Kenai doses first patient in Phase I trial of cell therapy for Parkinson’s
argenx to discontinue Phase III trials of thyroid eye disease therapy
Increasing trial activity in APAC region influences commercial supply chains
Alphyn secures $25m in Series B for trial of Zabalafin Hydrogel
Anova introduces AI patient matching solution for clinical trials
FDA grants clearance to Prilenia and Ferrer’s Phase III ALS therapy trial
